BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

230 related articles for article (PubMed ID: 8212748)

  • 1. [Current treatment of supraventricular tachycardia: drug therapy].
    Manz M; Lüderitz B
    Z Gesamte Inn Med; 1993 Sep; 48(9):430-8. PubMed ID: 8212748
    [TBL] [Abstract][Full Text] [Related]  

  • 2. [Pharmacology of modern anti-arrhythmia drugs in therapy of supraventricular tachycardia].
    Honerjäger P; Schmidt G
    Z Gesamte Inn Med; 1993 Sep; 48(9):425-9. PubMed ID: 8212747
    [TBL] [Abstract][Full Text] [Related]  

  • 3. [Therapy of atrial fibrillation with class III anti-arrhythmia agents].
    Follath F; Candinas R; Frielingsdorf J
    Herz; 1993 Feb; 18(1):20-6. PubMed ID: 8454249
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Pharmacologic management of supraventricular tachycardias in children. Part 2: Atrial flutter, atrial fibrillation, and junctional and atrial ectopic tachycardia.
    Luedtke SA; Kuhn RJ; McCaffrey FM
    Ann Pharmacother; 1997 Nov; 31(11):1347-59. PubMed ID: 9391691
    [TBL] [Abstract][Full Text] [Related]  

  • 5. [Problems with anti-arrhythmia therapy in atrial fibrillation].
    Breithardt G; Kottkamp H; Haverkamp W; Hindricks G; Fetsch T; Borggrefe M
    Z Kardiol; 1994; 83 Suppl 5():63-9. PubMed ID: 7846947
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Atrial fibrillation: rate control often better than rhythm control.
    Prescrire Int; 2004 Apr; 13(70):64-9. PubMed ID: 15148984
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Accessory pathway reciprocating tachycardia.
    Obel OA; Camm AJ
    Eur Heart J; 1998 May; 19 Suppl E():E13-24, E50-1. PubMed ID: 9717020
    [TBL] [Abstract][Full Text] [Related]  

  • 8. [Supraventricular tachycardia with wide QRS complexes during Vaughan-Williams class I anti-arrhythmic treatment. Diagnostic and therapeutic implications].
    Aouate P; Frank R; Fontaine G; Tonet J; Tageddine R; Benassar A; Turlure A; Jacquemin M; Laborde JP
    Arch Mal Coeur Vaiss; 1995 Dec; 88(12):1869-74. PubMed ID: 8729368
    [TBL] [Abstract][Full Text] [Related]  

  • 9. [Catheter ablation in supraventricular tachycardia].
    Pitschner HF; Neuzner J
    Z Kardiol; 1996; 85 Suppl 6():45-60. PubMed ID: 9064982
    [TBL] [Abstract][Full Text] [Related]  

  • 10. [Drug therapy of cardiac arrhythmias 199].
    Dietz A; Manz M
    Fortschr Med; 1997 Nov; 115(33):32, 34-6, 38. PubMed ID: 9480278
    [TBL] [Abstract][Full Text] [Related]  

  • 11. [Drug therapy in supraventricular arrhythmia].
    Follath F; Candinas R; Meyer B
    Schweiz Rundsch Med Prax; 1992 Apr; 81(18):579-81. PubMed ID: 1594845
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Using the right drug: a treatment algorithm for regular supraventricular tachycardias.
    Lévy S; Ricard P
    Eur Heart J; 1997 May; 18 Suppl C():C27-32. PubMed ID: 9152672
    [TBL] [Abstract][Full Text] [Related]  

  • 13. An evaluation of the strategy of maintenance of sinus rhythm by antiarrhythmic drug therapy after ablation and pacing therapy in patients with paroxysmal atrial fibrillation.
    Brignole M; Menozzi C; Gasparini M; Bongiorni MG; Botto GL; Ometto R; Alboni P; Bruna C; Vincenti A; Verlato R;
    Eur Heart J; 2002 Jun; 23(11):892-900. PubMed ID: 12042011
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Results of sotalol (Darob) therapy in supraventricular tachyarrhythmias.
    Toporan D; Protopopescu T; Ioan A; Paraschiv A
    Rom J Intern Med; 1998; 36(3-4):207-17. PubMed ID: 10822517
    [TBL] [Abstract][Full Text] [Related]  

  • 15. [Epidemiology and therapy of atrial fibrillation].
    Capucci A; Aschieri D; Villani GQ
    Ann Ital Med Int; 1996 Oct; 11 Suppl 2():5S-10S. PubMed ID: 9004821
    [TBL] [Abstract][Full Text] [Related]  

  • 16. [Supraventricular paroxysmal reentry tachycardia. Empirical and guided therapy].
    Piccolo E; Bonso A; Raviele A; Delise P
    Cardiologia; 1991 Aug; 36(8 Suppl):87-97. PubMed ID: 1817777
    [TBL] [Abstract][Full Text] [Related]  

  • 17. [Life-threatening ventricular tachycardia during flecainide treatment for symptomatic atrial fibrillation in a patient with a structural cardiac disorder].
    Rienstra M; Wiesfeld AC; van Veldhuisen DJ; van Gelder IC
    Ned Tijdschr Geneeskd; 2006 May; 150(18):1027-31. PubMed ID: 16715868
    [TBL] [Abstract][Full Text] [Related]  

  • 18. [Exogenous adenosine as an anti-arrhythmia agent].
    Tebbenjohanns J; Pfeiffer D; Schumacher B; Korte T; Jung W; Lüderitz B
    Z Kardiol; 1996; 85 Suppl 6():191-9. PubMed ID: 9064965
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Supraventricular tachycardia and pre-excitation syndromes: pharmacological therapy.
    Manz M; Lüderitz B
    Eur Heart J; 1993 Sep; 14 Suppl E():91-8. PubMed ID: 8223763
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Hemodynamic consequences of supraventricular tachycardias and their antiarrhythmic treatment.
    Yusoff K; Tai YT; Campbell RW
    Z Kardiol; 1988; 77 Suppl 5():137-42. PubMed ID: 3066035
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 12.